Glenmark Pharmaceuticals Limited — Carvedilol Exporter Profile
Indian Pharmaceutical Exporter · #4 for Carvedilol · $8.4M export value · DGFT Verified
Glenmark Pharmaceuticals Limited is the #4 Indian exporter of Carvedilol with $8.4M in export value and 257 verified shipments. Glenmark Pharmaceuticals Limited holds a 8.6% market share in Carvedilol exports across 2 countries. The company exports 28 pharmaceutical products worth $205.5M across 14 therapeutic categories.
Glenmark Pharmaceuticals Limited — Carvedilol Export Profile: Buyers & Destinations
Where Does Glenmark Pharmaceuticals Limited Export Carvedilol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $7.6M | 266 | 97.8% |
| UNITED STATES OF AMERICA | $160.0K | 4 | 2.1% |
| BAHRAIN | $11.0K | 2 | 0.1% |
Glenmark Pharmaceuticals Limited exports Carvedilol to 3 countries. The largest destination is UNITED STATES accounting for 97.8% of Glenmark Pharmaceuticals Limited's Carvedilol shipments, followed by UNITED STATES OF AMERICA (2.1%) and BAHRAIN (0.1%). These destinations reflect Glenmark Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.